SC 13G: Erasca, Inc.

AI Summary

SC 13G filing by Erasca, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) Common stock, $0.0001 par value per share (Title of Class o

Filing Documents

• tm2416033d1_sc13g.htm (SC 13G) — 176KB
• 0001104659-24-067180.txt ( ) — 178KB

From the Filing

SC 13G 1 tm2416033d1_sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Erasca, Inc. (Name of Issuer) Common stock, $0.0001 par value per share (Title of Class of Securities) 29479A108 (CUSIP Number) May 21, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise CUSIP No. 29479A108 Page 2 of 17 1. Names of Reporting Persons Venrock Healthcare Capital Partners III, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (1) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 16,216,216 (2) 7. Sole Dispositive Power 0 8. Shared Dispositive Power 16,216,216 (2) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 16,216,216 (2) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.5% (3) 12. Type of Reporting Person (See Instructions) PN (1) Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G. (2) Consists of (i) 2,580,000 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 257,838 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 13,378,378 shares held by Venrock Healthcare Capital Partners EG, L.P. (3) This percentage is calculated based upon 250,956,596 shares outstanding as of May 21, 2024, as disclosed in the Prospectus supplement dated May 16, 2024 filed with the Securities and Exchange Commission (the “ SEC ”) on May 17, 2024. CUSIP No. 29479A108 Page 3 of 17 1. Names of Reporting Persons VHCP Co-Investment Holdings III, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (1) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 16,216,216 (2) 7. Sole Dispositive Power 0 8. Shared Dispositive Power 16,216,216 (2) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 16,216,216 (2) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.5% (3) 12. Type of Reporting Person (See Instructions) OO (1) Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G. (2) Consists of (i) 2,580,000 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 257,838 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 13,378,378 shares held by Venrock Healthcare Capital Partners EG, L.P. (3) This percentage is calculated based upon 250,956,596 shares outstanding as of May 21, 2024, as disclosed in the Prospectus supplement dated May 16, 2024 filed with the SEC on May 17, 2024. CUSIP No. 29479A108 Page 4 of 17 1. Names of Reporting Persons Venrock Healthcare Capital Partners EG, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (1) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 16,216,216 (2) 7. Sole Dispositive Power 0 8. Shared Dispositive Power 16,216,216 (2) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 16,216,216 (2) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.5% (3) 12. Type of Reporting Person (See Instructions) PN (1) Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management II

View Full Filing

View this SC 13G filing on SEC EDGAR